Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
Songwei Duan, Xiaoyin Guan, Runxuan Lin, et al.
Neurobiology of Aging (2015) Vol. 36, Iss. 5, pp. 1792-1807
Closed Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Edward O. Olufunmilayo, Michelle B. Gerke-Duncan, R. M. Damian Holsinger
Antioxidants (2023) Vol. 12, Iss. 2, pp. 517-517
Open Access | Times Cited: 284
Microbial production of natural and non-natural flavonoids: Pathway engineering, directed evolution and systems/synthetic biology
Ramesh Prasad Pandey, Prakash Parajuli, Mattheos A. G. Koffas, et al.
Biotechnology Advances (2016) Vol. 34, Iss. 5, pp. 634-662
Open Access | Times Cited: 252
Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions
Abhijit Dey, Raktim Bhattacharya, Anuradha Mukherjee, et al.
Biotechnology Advances (2016) Vol. 35, Iss. 2, pp. 178-216
Closed Access | Times Cited: 213
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects
Pingal Pritam, Rahul Deka, Anuradha Bhardwaj, et al.
Biology (2022) Vol. 11, Iss. 2, pp. 212-212
Open Access | Times Cited: 110
Mechanistic Insights into the Pharmacological Significance of Silymarin
Karan Wadhwa, Rakesh Pahwa, Manish Kumar, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5327-5327
Open Access | Times Cited: 98
Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer’s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis
Samar R. Saleh, Aml Abd-Elmegied, Somaya Aly Madhy, et al.
International Journal of Pharmaceutics (2024) Vol. 658, pp. 124218-124218
Closed Access | Times Cited: 19
Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats
Hend M. Hussien, Aml Abd-Elmegied, Doaa A. Ghareeb, et al.
Food and Chemical Toxicology (2017) Vol. 111, pp. 432-444
Closed Access | Times Cited: 146
Hesperidin and Silibinin Ameliorate Aluminum-Induced Neurotoxicity: Modulation of Antioxidants and Inflammatory Cytokines Level in Mice Hippocampus
Ashok Jangra, Prajapati Kasbe, Surya Narayan Pandey, et al.
Biological Trace Element Research (2015) Vol. 168, Iss. 2, pp. 462-471
Closed Access | Times Cited: 103
Natural products as a potential modulator of microglial polarization in neurodegenerative diseases
Xin Jin, Mingyan Liu, Dongfang Zhang, et al.
Pharmacological Research (2019) Vol. 145, pp. 104253-104253
Closed Access | Times Cited: 92
Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
Antonella Amato, Simona Terzo, Flavia Mulè
Antioxidants (2019) Vol. 8, Iss. 12, pp. 608-608
Open Access | Times Cited: 92
Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications
Xin Wang, Zhen Zhang, Shuai-Cheng Wu
Journal of Agricultural and Food Chemistry (2020) Vol. 68, Iss. 42, pp. 11644-11664
Closed Access | Times Cited: 84
Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase
Sagheer Ahmed, Sidrah Tariq Khan, Muhammad Kazim Zargaham, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111609-111609
Open Access | Times Cited: 81
Cognitive impairments in type 2 diabetes, risk factors and preventive strategies
Garima Sharma, Arti Parihar, Tanay Talaiya, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 75
Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship
Jiao Li, Min Sun, Xiaodong Cui, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10020-10020
Open Access | Times Cited: 40
Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer’s disease
Sonal Dubey, Ekta Singh
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 717-730
Closed Access | Times Cited: 25
The pathophysiological signaling and efficacy of medicinal herbal compounds in Alzheimer’s disease
Shahram Darabi, Armin Ariaei, Enam Alhagh Charkhat Gorgich, et al.
Deleted Journal (2025) Vol. 29, Iss. 1, pp. 3-24
Open Access | Times Cited: 1
Effects of Silymarin on Diabetes Mellitus Complications: A Review
Aline Maria Stolf, Cibele C. Cardoso, Alexandra Acco
Phytotherapy Research (2017) Vol. 31, Iss. 3, pp. 366-374
Closed Access | Times Cited: 81
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease
Yu Wang, Hao Wang, Hongzhuan Chen
Current Neuropharmacology (2016) Vol. 14, Iss. 4, pp. 364-375
Open Access | Times Cited: 76
Inclusion complex with cyclodextrins enhances the bioavailability of flavonoid compounds: a systematic review
Bruno dos Santos Lima, S. Saravanan, Jullyana de Souza Siqueira Quintans, et al.
Phytochemistry Reviews (2019) Vol. 18, Iss. 5, pp. 1337-1359
Closed Access | Times Cited: 67
The Cyanthin Diterpenoid and Sesterterpene Constituents of Hericium erinaceus Mycelium Ameliorate Alzheimer’s Disease-Related Pathologies in APP/PS1 Transgenic Mice
Tsai-Teng Tzeng, Chien-Chih Chen, Chin‐Chu Chen, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 598-598
Open Access | Times Cited: 66
Silybin attenuates LPS-induced lung injury in mice by inhibiting NF-κB signaling and NLRP3 activation
Bo Zhang, Bing Wang, Shu-hua Cao, et al.
International Journal of Molecular Medicine (2017) Vol. 39, Iss. 5, pp. 1111-1118
Open Access | Times Cited: 62
Identification and molecular docking study of fish roe-derived peptides as potent BACE 1, AChE, and BChE inhibitors
Zhipeng Yu, Huizhuo Ji, Juntong Shen, et al.
Food & Function (2020) Vol. 11, Iss. 7, pp. 6643-6651
Closed Access | Times Cited: 53
Silibinin Ameliorates Formaldehyde-Induced Cognitive Impairment by Inhibiting Oxidative Stress
Pengsheng Wei, Xue Li, Shuai Wang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 29
Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight
Shovit Ranjan, Akash Gautam
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 19
The Interplay of Protein Aggregation, Genetics, and Oxidative Stress in Alzheimer’s Disease: Role for Natural Antioxidants and Immunotherapeutics
Ali Jawad, Kyonghwan Choe, Jun Sung Park, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 862-862
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top